Paper · 40819002
Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology.
Wang Y and 3 others. NPJ Digit Med, 2025. Cited by 29 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology. Papers, record 40819002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40819002
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrative machine learning models predict prostate cancer diagnosis and biochemical recurrence risk: Advancing precision oncology.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PL2024H044 | Natural Science Foundation of Heilongjiang Province | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40,567,132 | Understanding the Impact of Salvage Radiation on the Long-Term Natural History of Biochemically Recurrent Prostate Cancer After Radical Prostatectomy. | Cancer Med | 2025 | https://conductscience.org/library/papers/40567132 | PubMed |
| 2 | 40,082,107 | Prostate magnetic resonance imaging to predict grade concordance, extra prostatic extension, and biochemical recurrence after radical prostatectomy. | Urol Oncol | 2025 | https://conductscience.org/library/papers/40082107 | PubMed |
| 3 | 38,509,983 | Identification of circadian rhythm-related gene classification patterns and immune infiltration analysis in heart failure based on machine learning. | Heliyon | 2024 | https://conductscience.org/library/papers/38509983 | PubMed |
| 4 | 19,832,922 | PSA at postoperative three months can predict biochemical recurrence in patients with pathological T3 prostate cancer following radical prostatectomy. | Int J Urol | 2009 | https://conductscience.org/library/papers/19832922 | PubMed |
| 5 | 39,020,083 | Multi-omics machine learning to study host-microbiome interactions in early-onset colorectal cancer. | NPJ Precis Oncol | 2024 | https://conductscience.org/library/papers/39020083 | PubMed |
| 6 | 30,342,843 | Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. | Eur Urol | 2019 | https://conductscience.org/library/papers/30342843 | PubMed |
| 7 | 21,546,393 | Molecular signatures database (MSigDB) 3.0. | Bioinformatics | 2011 | https://conductscience.org/library/papers/21546393 | PubMed |
| 8 | 38,107,322 | Development and validation of a circulating tumor cells-related signature focusing on biochemical recurrence and immunotherapy response in prostate cancer. | Heliyon | 2023 | https://conductscience.org/library/papers/38107322 | PubMed |
| 9 | 38,918,844 | Identification of metastasis-related genes for predicting prostate cancer diagnosis, metastasis and immunotherapy drug candidates using machine learning approaches. | Biol Direct | 2024 | https://conductscience.org/library/papers/38918844 | PubMed |
| 10 | 40,275,794 | Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer. | BJU Int | 2025 | https://conductscience.org/library/papers/40275794 | PubMed |
1 to 10 of 41
See all 41 referencesCited by29
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,930,175 | Interpretable Machine Learning Prognostic Model Integrating Inflammatory-Nutritional Biomarkers for Post-Prostatectomy Biochemical Recurrence: Development, Internal Validation, and Translational Target Exploration. | Curr Oncol | 2026 | https://conductscience.org/library/papers/42930175 | PubMed |
| 42,729,077 | Multi-omics integration identifies HSPA4 as a therapeutic target and reveals DON-induced endoplasmic reticulum stress in bladder cancer. | Transl Androl Urol | 2026 | https://conductscience.org/library/papers/42729077 | PubMed |
| 42,591,440 | An externally validated lactylation-associated prognostic signature for overall survival prediction in lung adenocarcinoma identifies TUBA1C as a candidate gene. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42591440 | PubMed |
| 42,374,002 | Development and validation of a novel T cell exhaustion-related signature to predict prognosis in patients with breast cancer. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42374002 | PubMed |
| 42,317,213 | From Germline Susceptibility to Therapeutic Vulnerability: DNA Damage Response Gene Mutations Driving Multiple Myeloma Evolution and Precision Therapy. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42317213 | PubMed |
| 42,295,562 | Machine learning-based identification of basement membrane-related signature to predict recurrence and immunotherapy benefit in bladder cancer. | Immunol Res | 2026 | https://conductscience.org/library/papers/42295562 | PubMed |
| 42,293,334 | Molecular Subtyping Based on EGFR Mutation-Associated Genes and the Prognostic Role of TRAF2 in Lung Adenocarcinoma. | Hum Mutat | 2026 | https://conductscience.org/library/papers/42293334 | PubMed |
| 42,278,330 | A Metabolic-Related Gene Signature for Predicting Biochemical Recurrence After Radical Prostatectomy: An Integrative Analysis and Targeted Therapeutic Validation. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42278330 | PubMed |
| 42,244,150 | Machine learning-guided multi-omics suggests iron-dependent hormonal signaling drives root morphological plasticity in wheat under temperature stress. | New Phytol | 2026 | https://conductscience.org/library/papers/42244150 | PubMed |
| 42,204,546 | Machine learning-based prognostic model integrating preoperative HALP score and lactate dehydrogenase for predicting postoperative recurrence of prostate cancer. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42204546 | PubMed |
1 to 10 of 29
See all 29 cited byGenes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ASPN | 54,829 | PubTator's text mining | https://conductscience.org/library/genes/54829 | NCBI Gene |
| BCR | 613 | PubTator's text mining | https://conductscience.org/library/genes/613 | NCBI Gene |
| BGN | 633 | PubTator's text mining | https://conductscience.org/library/genes/633 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| COL1A1 | 1,277 | PubTator's text mining | https://conductscience.org/library/genes/1277 | NCBI Gene |
| CTHRC1 | 115,908 | PubTator's text mining | https://conductscience.org/library/genes/115908 | NCBI Gene |
| EGFR | 1,956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FAP | 2,191 | PubTator's text mining | https://conductscience.org/library/genes/2191 | NCBI Gene |
| GAPDH | 2,597 | PubTator's text mining | https://conductscience.org/library/genes/2597 | NCBI Gene |
1 to 10 of 24
See all 24 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40819002
GET https://conductscience.org/api/papers/v1/40819002/references?page=2